Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now


View All News
February 15, 2022

Scout Bio to Present at Upcoming Animal Health Conferences

PHILADELPHIA, February 15, 2022 – Scout Bio, a biotechnology company developing therapeutic proteins and one-time AAV gene therapies for major chronic pet health conditions, today announced that it will present at two conferences in February 2022. They include:

  • Animal Health, Nutrition and Technology Innovation Europe (In-person). Scout Bio is a sponsor of the event, and management will host a technical insights session reviewing the company’s platform and pipeline on February 22 at 3:15 p.m. GMT.
  • Bank of America Securities Animal Health Summit (Virtual). Scout Bio Chief Executive Officer Mark Heffernan, Ph.D., will provide a corporate overview on Thursday, February 25, 2022 at 10:50-11:30 a.m. EST.

About Scout Bio
Scout Bio is a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies for major chronic pet health conditions. Scout Bio’s therapeutics are designed to induce long-term expression of therapeutic proteins in pet patients using AAV vector technology. Scout Bio has a research and development collaboration with the University of Pennsylvania’s Gene Therapy Program, a leader in the field of genetic medicine research. Scout Bio is a private company headquartered in Philadelphia, Pennsylvania. For more information, see www.scoutbio.co

For further information, please contact:
Fran Gaconnier
Scout Bio

  • News

Scout Bio Announces Appointment Of Chief Manufacturing Officer

Experienced global animal health biologics executive to drive manufacturing strategies and advance pipeline of multiple animal health monoclonal antibodies (mAbs) and novel adeno-associated virus (AAV) therapeutics. PHILADELPHIA, JULY 1,…

  • News

Scout Bio To Present Positive Clinical Data On SB-001 For Feline CKD-Anemia at Leading Veterinary Medicine Forum

Scout Bio’s research was selected for presentation at the American College of Veterinary Internal Medicine (ACVIM) Forum Three lectures will present Scout Bio’s technology, new areas of research, and…

  • News

Scout Bio to Feature at Morgan Stanley Animal Health Biopharma Global KOL Summit

Leading veterinary biopharma innovators, experts, and investors in gene therapy technologies, including Aaron Schacht and Mark Heffernan, to present opportunities for therapeutic innovation in rapidly growing market PHILADELPHIA, June…